Core Laboratories N.V.

NYSE: CLB · Real-Time Price · USD
10.61
-0.13 (-1.21%)
At close: Aug 14, 2025, 3:59 PM
10.60
-0.09%
Pre-market: Aug 15, 2025, 08:45 AM EDT

Core Laboratories Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
32.15M 37.02M 19.66M 20.22M
Depreciation & Amortization
14.95M 15.78M 17.16M 18.52M
Stock-Based Compensation
3.75M 13.97M 7.76M 19.09M
Other Working Capital
1.6M -300K -15.46M -12.75M
Other Non-Cash Items
-3.03M -2.41M 4.97M -3.01M
Deferred Income Tax
674K -10.81M 433K 6.01M
Change in Working Capital
7.88M -28.77M -25.02M -24.25M
Operating Cash Flow
56.39M 24.79M 24.96M 36.58M
Capital Expenditures
-13.03M -10.58M -10.22M -13.54M
Cash Acquisitions
n/a n/a 240K 873K
Purchase of Investments
n/a n/a n/a 13.54M
Sales Maturities Of Investments
n/a n/a n/a 726K
Other Investing Acitivies
6.63M 3.93M 6.12M -11.82M
Investing Cash Flow
-6.39M -6.65M -3.86M -10.22M
Debt Repayment
-38M -9M -15M -71M
Common Stock Repurchased
-5.31M -2.2M -3.9M -8.26M
Dividend Paid
-1.88M -1.87M -1.85M -1.83M
Other Financial Acitivies
-775K -5.38M -2.62M -1.37M
Financial Cash Flow
-45.96M -18.45M -23.38M -22.46M
Net Cash Flow
4.04M -308K -2.27M 3.9M
Free Cash Flow
43.36M 14.21M 14.74M 23.04M